The role of gastrodin in the management of CNS‐related diseases: Underlying mechanisms to therapeutic perspectives
Xirui He,
No information about this author
Xufei Chen,
No information about this author
Yan Yang
No information about this author
et al.
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
38(11), P. 5107 - 5133
Published: Aug. 15, 2024
Abstract
Central
nervous
system
(CNS)‐related
diseases
have
a
high
mortality
rate,
are
serious
threat
to
physical
and
mental
health,
always
been
an
important
area
of
research.
Gastrodin,
the
main
active
metabolite
Gastrodia
elata
Blume,
used
in
Chinese
medicine
food,
has
wide
range
pharmacological
effects,
mostly
related
CNS
disorders.
This
review
aims
systematically
summarize
discuss
effects
underlying
mechanisms
gastrodin
treatment
diseases,
assess
its
potential
for
further
development
as
lead
drug
both
biomedicine
traditional
medicine.
Studies
on
indicate
that
it
may
exert
anti‐neurodegenerative,
cerebrovascular
protective,
ameliorative
diabetic
encephalopathy,
perioperative
neurocognitive
dysfunction,
epilepsy,
Tourette's
syndrome,
depression
anxiety,
sleep
disorders
through
various
mechanisms.
To
date,
110
products
approved
clinical
use,
but
multicenter
case–control
studies
relatively
scarce.
Preclinical
confirmed
can
be
treat
CNS‐related
However,
concerns
need
addressed
context
likely
non‐specific,
assay
interfering
when
is
studied
using
vitro
silico
approaches,
calling
systematic
assessment
evidence
date.
High‐quality
trials
should
priority
evaluate
therapeutic
safety
efficacy
gastrodin.
Further
experimental
research
appropriate
vivo
models
also
needed,
focusing
neurodegenerative
cerebral
ischemic
hypoxic
brain
damage
caused
by
methamphetamine
or
heavy
metals,
epilepsy.
Language: Английский
Gastrodin Ameliorates Tau Pathology and BBB Dysfunction in 3xTg‐AD Transgenic Mice by Regulating the ADRA1/NF‐κB/NLRP3 Pathway to Reduce Neuroinflammation
Bo Li,
No information about this author
Li Wang,
No information about this author
Yan Xiao
No information about this author
et al.
Phytotherapy Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 18, 2025
ABSTRACT
Background
and
aim:
Gastrodin,
an
active
compound
derived
from
the
traditional
Chinese
herbal
medicine
Gastrodia,
demonstrates
a
variety
of
pharmacological
effects,
particularly
in
enhancement
neural
functions.
Thus,
aim
this
study
is
to
explore
therapeutic
effects
gastrodin
on
Alzheimer's
disease
(AD)
its
underlying
molecular
mechanisms.
Experimental
procedure:
Cognitive
function
was
assessed
via
Morris
water
maze
Y‐maze
tests.
Tau
pathology,
neuroinflammation,
BBB
dysfunction
were
analyzed
using
various
techniques,
including
Western
blot,
immunohistochemistry,
ELISA.
ADRA1
overexpression
induced
by
lentiviral
infection,
gastrodin's
impact
NF‐κB
p65,
NLRP3,
IL‐1β,
IL‐18
levels
evaluated.
Key
results:
In
vivo
experiment,
enhanced
learning
spatial
memory
3xTg‐AD
mice,
as
well
reducing
p‐Tau
protein
expression
hippocampus
cortex.
Gastrodin
inhibited
ADRA1/NF‐κB/NLRP3
pathway,
which
decreased
glial
cell
activation
inflammatory
cytokines
IL‐1β
IL‐18,
improving
neuron
function.
vitro
NF‐κB/NLRP3
pathway
due
prevented
Aβ
42
‐induced
increase
SH‐SY5Y
cells.
It
also
reduced
cytokine
release,
restoring
tight
junction
bEnd.3
Conclusions
implications:
ameliorates
abilities
alleviating
neuroinflammation
tau
structure
neurons
BBB,
suggesting
that
may
serve
effective
drug
for
treatment
AD.
Language: Английский
Gastrodin Alleviates Tau Pathology by Targeting the Alzheimer's Risk Gene FERMT2, Reversing the Reduction in Brain Viscoelasticity
Li Wang,
No information about this author
Bo Li,
No information about this author
Zhi Tang
No information about this author
et al.
CNS Neuroscience & Therapeutics,
Journal Year:
2025,
Volume and Issue:
31(3)
Published: March 1, 2025
The
pathogenesis
of
Alzheimer's
disease
(AD)
remains
incompletely
elucidated,
and
there
is
a
notable
deficiency
in
effective
safe
therapeutic
interventions.
influence
brain
matrix
viscoelasticity
on
the
progression
AD
has
frequently
been
underestimated.
It
imperative
to
elucidate
these
overlooked
pathogenic
factors
innovate
novel
strategies
for
AD.
Gastrodin,
bioactive
constituent
derived
from
traditional
Chinese
medicinal
herb
Gastrodia
elata,
exhibits
range
pharmacological
properties,
notably
enhancement
neural
function.
Nevertheless,
underlying
mechanisms
its
action
remain
insufficiently
elucidated.
Consequently,
this
study
seeks
examine
effects
gastrodin
context
AD,
with
particular
emphasis
potential
viscoelastic
properties
matrix.
This
employs
methodologies,
including
Morris
water
maze
test,
Y-maze
spontaneous
alternation
atomic
force
microscopy
(AFM),
immunofluorescence,
transmission
electron
microscopy,
molecular
docking,
Cellular
Thermal
Shift
Assay
(CETSA),
demonstrate
that
mitigates
tau
pathology
by
modulating
FERMT2,
thereby
reversing
deterioration
mechanical
brain.
Gastrodin
administration
via
gavage
demonstrated
mitigate
cognitive
decline
associated
attenuate
hyperphosphorylation
protein
hippocampus
cortex,
ameliorate
synaptic
damage.
Additionally,
was
observed
counteract
reduction
3xTg-AD
mice,
as
evidenced
upregulation
extracellular
components
pertinent
viscoelasticity,
collagen
types
I
IV.
Furthermore,
docking
CETSA
revealed
strong
binding
affinity
between
FERMT2.
treatment
resulted
FERMT2
fluorescence
intensity,
which
selectively
expressed
astrocytes.
contributed
restoration
blood-brain
barrier
(BBB)
modulated
expression
levels
inflammatory
mediators
interleukin-6
(IL-6),
tumor
necrosis
factor-alpha
(TNF-α),
metallopeptidase
8
(MMP8).
pathology,
enhancing
learning
memory
mouse
models.
effect
may
be
mediated
through
modulation
cerebral
mechanosensor
facilitates
structure
process
potentially
linked
maintenance
BBB
integrity
factor
release.
Language: Английский
The Pharmacological Effects of Gastrodin and the Progress in the Treatment of Neurological Disorders
Han Guo,
No information about this author
Dongmei Cheng,
No information about this author
Chong-xi ZHANG
No information about this author
et al.
The American Journal of Chinese Medicine,
Journal Year:
2025,
Volume and Issue:
53(03), P. 803 - 831
Published: Jan. 1, 2025
Gastrodia
elata
Blume,
a
traditional
medicinal
herb
primarily
used
in
Asian
countries
such
as
China,
has
long
been
valued
for
treating
headaches,
dizziness,
spasms,
epilepsy,
strokes,
forgetfulness,
and
other
ailments.
Gastrodin,
glycoside
analog
major
bioactive
component
of
garnered
significant
scientific
attention
owing
to
its
extensive
pharmacological
effects.
It
is
commonly
obtained
through
plant
extraction,
chemical
synthesis,
biosynthesis.
Gastrodin
exhibits
remarkable
modulatory
effects
on
the
central
nervous
system
(CNS),
with
promising
applications
neurodegenerative
diseases
Parkinson’s
disease
(PD)
Alzheimer’s
(AD),
affective
cognitive
disorders.
Furthermore,
pharmacokinetics
(PK)
gastrodin
extensively
reviewed.
As
small
molecule
drug,
this
study
focused
efficiency
molecular
mechanisms
CNS
disorders,
aiming
elucidate
interactions
targets.
This
provides
valuable
insights
development
addresses
drawbacks
unclear
Chinese
medicine.
Language: Английский
A New Frontier in Phytotherapy: Harnessing the Therapeutic Power of Medicinal Herb-derived miRNAs
Current Pharmaceutical Design,
Journal Year:
2024,
Volume and Issue:
30(38), P. 3009 - 3017
Published: Aug. 20, 2024
:
Medicinal
herbs
have
been
utilized
in
the
treatment
of
various
pathologic
conditions,
including
neoplasms,
organ
fibrosis,
and
diabetes
mellitus.
However,
precise
pharmacological
actions
plant
miRNAs
animals
remain
to
be
fully
elucidated,
particularly
terms
their
therapeutic
efficacy
mechanism
action.
In
this
review,
some
important
from
foods
medicinal
are
presented.
Plant
exhibit
a
range
properties,
such
as
anti-cancer,
anti-fibrosis,
anti-viral,
anti-inflammatory
effects,
neuromodulation,
among
others.
These
results
not
only
demonstrated
cross-species
regulatory
effect,
but
also
suggested
that
bioactive
components.
This
shows
promising
prospect
for
used
drugs.
Here,
properties
underlying
mechanisms
highlighted,
which
can
provide
new
insights
clarifying
suggest
way
developing
Language: Английский
Combined administration of catalpol, puerarin, gastrodin, and borneol modulates the Tlr4/Myd88/NF-κB signaling pathway and alleviates microglia inflammation in Alzheimer’s disease
Huijing Ren,
No information about this author
Ling Tang,
No information about this author
Zhiying Yuan
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 31, 2024
Alzheimer's
Disease
(AD)
is
a
progressive
neurodegenerative
disorder
affecting
millions
of
people
worldwide,
with
no
effective
treatment
currently
available.
In
recent
decades,
various
traditional
Chinese
medicines
(TCMs)
and
their
active
ingredients
have
shown
the
potential
to
attenuate
pathogenesis
AD
in
cellular
animal
models.
However,
effects
TCM
formulas,
which
are
typically
administered
practice,
been
less
studied.
This
study
aims
investigate
therapeutic
several
formulas
consisting
4
components
herbal
components:
catalpol,
puerarin,
gastrodin,
borneol,
on
streptozotocin
(STZ)-induced
models
cells
rats.
The
new
object
recognition
(NOR),
elevated
plus
maze
(EMP),
Morris
water
(MWM)
tests
were
used
evaluate
cognitive
functions
Golgi
staining,
Haematoxylin
Eosin
(HE)
Nissl
staining
analyses
employed
assess
physiology
hippocampal
tissues.
Gene
expression
profiles
analyzed
transcriptomics
reverse
transcription
quantitative
polymerase
chain
reaction
analysis,
while
protein
levels
determined
using
immunoblotting,
immunohistochemical,
immunofluorescence.
production
cytokines
was
evaluated
enzyme-linked
immunosorbent
assay.
results
demonstrated
that
combined
administration
these
(CPGB)
had
superior
mitigating
cell
model,
as
evidenced
by
reduced
pro-inflammatory
cytokine
decreased
deposition
Aβ
protein.
Further
Language: Английский